tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Actuate Therapeutics announces common stock offering, no amount given
PremiumThe FlyActuate Therapeutics announces common stock offering, no amount given
20d ago
Actuate Therapeutics files $250M mixed securities shelf
Premium
The Fly
Actuate Therapeutics files $250M mixed securities shelf
27d ago
Actuate Therapeutics initiated with a Buy at B. Riley
Premium
The Fly
Actuate Therapeutics initiated with a Buy at B. Riley
1M ago
Actuate Therapeutics announces end of Phase 1 portion of elraglusib study
PremiumThe FlyActuate Therapeutics announces end of Phase 1 portion of elraglusib study
2M ago
Actuate Therapeutics Secures $4.7M in Private Placement
Premium
Company Announcements
Actuate Therapeutics Secures $4.7M in Private Placement
3M ago
Actuate highlights results from subgroup analysis of Phase 2 elraglusib trial
Premium
The Fly
Actuate highlights results from subgroup analysis of Phase 2 elraglusib trial
3M ago
Actuate Therapeutics Reports Positive Phase 2 Trial Results
PremiumCompany AnnouncementsActuate Therapeutics Reports Positive Phase 2 Trial Results
4M ago
Promising Clinical Trial Results Justify Buy Rating for Actuate Therapeutics’ Elraglusib
Premium
Ratings
Promising Clinical Trial Results Justify Buy Rating for Actuate Therapeutics’ Elraglusib
4M ago
Actuate Therapeutics Elects Directors at Annual Meeting
Premium
Company Announcements
Actuate Therapeutics Elects Directors at Annual Meeting
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100